Novo Nordisk Sues Weight-Loss Jab Competitor
Novo Nordisk has filed a lawsuit against iDexis, alleging infringement related to compounded weight-loss injections. iDexis is accused of using Novo Nordisk's intellectual property.
Topics
Developing
- 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Novo Nordisk sues iDexis over compounded weight-loss jabs”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade